-
BGV announces the close of the FIRST II fund to accelerate Dutch life science spinouts in chronic diseases
BioGeneration Ventures (BGV) has announced the close of FIRST II (Fonds InvesteringsRijpe Starters), reaching 12 million euro to support the creation and development of early-stage life sciences start-ups emerging from Dutch academic research.
read more
RegMed XB welcomed Japanese delegation to strengthen cross-border collaboration (18–20 February)
From 18–20 February, RegMed XB proudly hosted a high-level Japanese delegation as part of an intensive knowledge exchange visit between the Netherlands and Japan. The delegation included representatives from Nakanoshima Qross, Cuorips Inc., and Rege Nephro Co., Ltd..
read more
Inspiring stories and real-world impact at the DCVA RegMed XB Community Event
On 12 February, the DCVA RegMed XB community came together during the Dutch CardioVascular Alliance (DCVA) RegMed XB Community event.
read more -
Podcast, Leaders in Life Sciences, 18 January 2023: Bernard Mulder
-
